Blood samples were collected within 3 months of death from all enrolled patients, and cfDNA was extracted at initial diagnosis prior to systemic antitumor-treatment (including EGFR-TKIs). Whole blood (12 mL) was collected in ethylenediaminetetraacetic acid tubes and centrifuged at 700 × g (2000 rpm) for 10 min within 2 h of blood collection, as described previously37. cfDNA was extracted immediately from the plasma supernatant (4 mL) using a QIAAMP CIRCULATING NUCLEIC ACID KIT (Qiagen), and germline DNA was extracted from whole blood cells, obtained as the pellet in centrifugation, using a QIAAMP DNA MINI KIT (Qiagen). The extracted DNA was stored at − 20 °C until use. The concentration and quality of cfDNA and germline DNA were measured using the abovementioned methods.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.